Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Craneware plc (LSE:CRW) Shares Rise 2.55% as $185m Recurring Revenue Base, Cost Review and AI Partnership Help Rebuild Confidence

Craneware reported FY26 revenue of $206.0 million, flat against $205.7 million. Chief Executive Keith Neilson said the company was deeply disappointed by the results, urging investors not to overlook the strong foundations. Adjusted EBITDA rose 3% to $67.1 million, a 33% margin, and operating …

Ankur Sharma | 06 October 2026

Creo Medical Group Plc (LSE:CREO) Shares Jump 3.11% as 45% Revenue Growth and Path to Profitability Rekindle Investor Interest

Creo, based in Chepstow, Wales, develops minimally invasive electrosurgical devices that bring advanced energy to endoscopy, helping clinicians treat pre-cancerous and cancerous lesions without major surgery. Revenue for the first half of 2026 rose 45% to £3.2 million from £2.2 million, in line with …

Ankur Sharma | 06 October 2026

DotDigital Group PLC (LSE:DOTD) Shares Climb 3.07% as 18% ARR Growth, AI Agents Launch and Acquisitions Power Marketing Tech Momentum

Investors have been encouraged by the improving organic growth rate shown in the company's FY26 trading update and full-year reporting, as well as the early success of its recent acquisitions.

Ankur Sharma | 06 October 2026

Can Molecule Group’s New Identity Accelerate Its UK ePharmacy Growth Story? (LSE:MOL)

• Shares began trading under the new LSE:MOL ticker on 5 October 2026.

Ankur Sharma | 06 October 2026

Can Avacta’s £12.5 Million Fundraise Accelerate Its Oncology Pipeline? (LSE:AVCT)

• The proposed issue price is 68p per new share.

Ankur Sharma | 06 October 2026

Why EKF Diagnostics (LSE:EKF) Expects a Better Second Half in Point-of-Care and Life Sciences

EKF Diagnostics is quoted on AIM under the code EKF. It operates two divisions. Point-of-Care sells diagnostic analysers and consumables, including haematology products such as HemataSTAT and Hemo Control. Life Sciences supplies reagents, notably its beta-hydroxybutyrate (β-HB) LiquiColor test, and provides fermentation and contractManufacturingservices, …

Divya Sood | 05 October 2026

How Shield Therapeutics (LSE:STX) Reached a Half-Year Operating Profit With Help From International Milestones

Shield Therapeutics is an AIM-quoted pharmaceutical company whose lead product, ferric maltol, is sold as ACCRUFeR in the US and through partners elsewhere. It is an oral treatment for iron deficiency. The US is its most important market, while licensing partners such as Norgine …

Divya Sood | 05 October 2026

Why Did Reckitt Benckiser Group plc LSE:RKT Rise 0.16% Amid a Firmer Tone Across London-Listed Consumer Health Shares?

Reckitt Benckiser Group plc — LSE:RKT closed 0.16% higher on05 October 2026, with the shares at 4,933p after a gain of 8p on the day.

Ishan Mudgal | 05 October 2026

Why Did Inspiration Healthcare Group plc LSE:IHC Close Unchanged Amid Steady Trading Across London-Listed Healthcare Shares?

Inspiration Healthcare Group plc — LSE:IHC closed unchanged on05 October 2026, with the shares at 18.5p, unchanged on the day.

Ishan Mudgal | 05 October 2026

Why Did ConvaTec Group Plc LSE:CTEC Rise 0.46% Amid a Firmer Tone Across London-Listed Healthcare Shares?

ConvaTec Group Plc — LSE:CTEC closed 0.46% higher on05 October 2026, with the shares at 217.6p after a gain of 1p on the day.

Ishan Mudgal | 05 October 2026
Support

Hi! How can we help you today?

Loading…